reports
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
S&P 500 Holding Above Prior Breakout Level Yet Again As discussed throughout the first half of January, we continue to believe that tariffs will mostly be used as a negotiation tactic, and much like Trump's prior presidency, will be much less impactful than feared. We reiterated this in yesterday's pre-market ETF Pathfinder, also noting "we anticipate the Canada/Mexico tariffs to be resolved relatively quickly, and therefore we view the latest pullback as a buying opportunity." Sure enough, bot...
NTRA NATERA
MMSI MERIT MEDICAL SYSTEMS INC.
MDT MEDTRONIC PLC
LINC LINCOLN EDUCATIONAL SERVICES
FMS FRESENIUS MEDICAL CARE AG & CO. KGAA ADS
BMY BRISTOL-MYERS SQUIBB COMPANY
APEI AMERICAN PUBLIC EDUCATION
BSX. BELO SUN MINING CORP.
PEN PANORO ENERGY ASA
UTI UNIVERSAL TECHNICAL INSTITUTE INC.
LAUR LAUREATE EDUCATION INC. CLASS A
ATGE ADTALEM GLOBAL EDUCATION INC.
DGS. DIVIDEND GROWTH SPLIT
GH GUARDANT HEALTH
STRA STRATEGIC EDUCATION INC.
LRN STRIDE INC
LH LABCORP HOLDINGS INC
GSK GSK PLC
PROD PROSVETNO DELO AD ORD
- Dave Nicoski
- Ross LaDuke
MLAB MESA LABORATORIES INC.
LOCO EL POLLO LOCO HOLDINGS INC
JWN NORDSTROM INC.
HNRG HALLADOR ENERGY CO.
EQT EQT CORPORATION
CRK COMSTOCK RESOURCES INC.
AROW ARROW FINANCIAL CORP.
PRA PROASSURANCE CORPORATION
VMI VALMONT INDUSTRIES INC.
ZUMZ ZUMIEZ INC.
KIDS ORTHOPEDIATRICS CORP
FNKO FUNKO CLASS A
ST SENSATA TECHNOLOGIES HOLDING PLC
LOVE LOVESAC
GH GUARDANT HEALTH
WOOF PETCO HEALTH AND WELLNESS
SGHT SIGHT SCIENCES INC
BRCC BRC INC
BORR BORR DRILLING LTD
PFHC PROFRAC HLDG CORP
OBIO ORCHESTRA BIOMED HOLDINGS INC
BG BUNGE LIMITED
RNAC CARTESIAN THERAPEUTICS INC
AGEN AGENUS INC.
GIII G III APPAREL GROUP LTD COM
RVTTY ROVIO ENTERTAINMENT OYJ UNSPONS ADR
- Jonathan Moreland
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
SAIA SAIA INC.
RYI RYERSON HOLDING CORPORATION
RM REGIONAL MANAGEMENT CORP
RHP RYMAN HOSPITALITY PROPERTIES INC.
PENN PENN NATIONAL GAMING INC.
LTRX LANTRONIX INC.
KMPR KEMPER CORPORATION
HUBB HUBBELL INCORPORATED CLASS B
HOO HERBALIFE NUTRITION LTD.
FFIN FIRST FINANCIAL BANKSHARES INC
CTRN CITI TRENDS INC.
CNMD CONMED CORPORATION
AXS AXIS CAPITAL HOLDINGS LIMITED
AMH AMERICAN HOMES 4 RENT CLASS A
AIN ALBANY INTERNATIONAL CORP. CLASS A
HWBK HAWTHORN BANCSHARES
EFR ENERGY FUELS
SABR SABRE CORP.
ALPN ALPINE SELECT AG
HTLD HEARTLAND EXPRESS INC.
MAC MACERICH COMPANY
HI HILLENBRAND INC.
GLO CLOUGH GLOBAL OPPORTUNITIES FUND
WDFC WD-40 COMPANY
PK PARK HOTELS & RESORTS INC.
CRVS CORVUS PHARMACEUTICALS
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
EAF GRAFTECH INTERNATIONAL
FRAF FRANKLIN FINANCIAL SERVICES CO.
BBDC BARINGS BDC INC.
GH GUARDANT HEALTH
MCFT MASTERCRAFT BOAT HOLDINGS
HQL TEKLA LIFE SCIENCES INVESTORS
CZR CAESARS ENTERTAINMENT INC
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
PSTV PLUS THERAPEUTICS INC
CTOS CUSTOM TRUCK ONE SOURCE
TBBK INC.
MEGI THE BANCORP
NPCT INC.
RXO_w MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
BYON NUVEEN CORE PLUS IMPACT FD
VSTS_w RXO INC
NBBK BEYON 3D LTD
ASGI VESTIS CORPORATION
EYPT NB BANCORP INC.
DBD ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
EYEPOINT PHARMACEUTICALS
INC.
DIEBOLD NIXDORF INCORPORATED
- Jonathan Moreland
SAIA SAIA INC.
RYI RYERSON HOLDING CORPORATION
LTRX LANTRONIX INC.
HXL HEXCEL CORPORATION
HOO HERBALIFE NUTRITION LTD.
AIN ALBANY INTERNATIONAL CORP. CLASS A
HWBK HAWTHORN BANCSHARES
HI HILLENBRAND INC.
GLO CLOUGH GLOBAL OPPORTUNITIES FUND
EAF GRAFTECH INTERNATIONAL
GH GUARDANT HEALTH
DNA GINKGO BIOWORKS HOLDINGS
TBBK INC.
RXO_w THE BANCORP
VSTS_w INC.
CFFI RXO INC
RENT VESTIS CORPORATION
C&F FINANCIAL CORPORATION
RENT THE RUNWAY INC
- Jonathan Moreland
MIXT MIX TELEMATICS ADR
LOB LIVE OAK BANCSHARES
GME GAMESTOP CORP. CLASS A
GCO GENESCO INC.
AAP ADVANCE AUTO PARTS INC.
ZUMZ ZUMIEZ INC.
PLSE PULSE BIOSCIENCES
COGT COGINT
GH INC.
EPSN GUARDANT HEALTH
NRGX EPSILON ENERGY LIMITED
DIBS PIMCO ENERGY & TACTICAL CREDIT OPPORTUNITIES FUND
1STDIBS.COM
INC.
- Dave Nicoski
- Ross LaDuke
Vermilion Short Shots: Technically Vulnerable Stocks
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
AMN AMN HEALTHCARE SERVICES INC.
VET VERMILION ENERGY INC.
TTGT TECHTARGET INC.
TSN TYSON FOODS INC. CLASS A
RGNX REGENXBIO INC.
MDT MEDTRONIC PLC
LAZ LAZARD LTD CLASS A
KSS KOHL'S CORPORATION
JLL JONES LANG LASALLE INCORPORATED
ESS ESSEX PROPERTY TRUST INC.
DG DOLLAR GENERAL CORPORATION
CLFD CLEARFIELD INC.
BANF BANCFIRST
WFT. WEST FRASER TIMBER CO. LTD.
WD WALKER & DUNLOP INC.
CCRN CROSS COUNTRY HEALTHCARE INC.
MDRX ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
BMTA BRITISH AMERICAN TOBACCO PLC ADS
SNDX SYNDAX PHARMACEUTICALS
MED MEDIFAST INC.
NTR NUTRIEN LTD.
HOG HARLEY-DAVIDSON INC.
CBR CABRAL GOLD INC
INVA INNOVIVA INC.
GH GUARDANT HEALTH
ALLO ALLOGENE THERAPEUTICS
CI CIGNA CORPORATION
SILK SILK ROAD MEDICAL
LHX L3HARRIS TECHNOLOGIES INC
BEAM BEAM THERAPEUTICS
LESL LESLIES
PRCT PROCEPT BIOROBOTICS CORP
VERV VERVE THERAPEUTICS INC
STER STERLING CHECK CORP
EVA ENVIVA PARTNERS LP
AMPS ALTUS POWER INC
- Jonathan Moreland
OCFC OCEANFIRST FINANCIAL CORP.
MTDR MATADOR RESOURCES COMPANY
HBIO HARVARD BIOSCIENCE INC.
HASI HANNON ARMSTRONG SUSTAINABLE INFRASTRUCTURE CAPITAL INC.
DAR DARLING INGREDIENTS INC.
CLDT CHATHAM LODGING TRUST
CCNE CNB FINANCIAL CORP. (PENNSYLVANIA)
INBK FIRST INTERNET BANCORP
ISSC INNOVATIVE SOLUTIONS & SUPPORT INC.
JELD JELD-WEN HOLDING INC.
DK DELEK US HOLDINGS INC
BCBP BCB BANCORP INC.
GH GUARDANT HEALTH
SCHW THE CHARLES SCHWAB CORPORATION
PEAK HEALTHPEAK PROPERTIES INC.
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
RILY B. RILEY FINANCIAL
ENVX ENOVIX CORP
BPRN BANK OF PRINCETON
GUARDANT HEALTH presents increased market risk and shows a lower ratin...
The independent financial analyst theScreener just requalified the risk of GUARDANT HEALTH (US), active in the Biotechnology industry. As regards its fundamental valuation, the title receives a new star(s) and now shows 1 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and can be qualified as risky. theScreener considers that these elements lead to an overall rating downgrade to Slightly Negative while the title remains exposed to strong pressure. As of the anal...
New Data at IASLC 2021 World Conference on Lung Cancer Demonstrates Ad...
New Data at IASLC 2021 World Conference on Lung Cancer Demonstrates Advantages of Using the Guardant360® Liquid Biopsy Blood Test for Comprehensive Genomic Profiling in Advanced Lung Cancer REDWOOD CITY, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) along with leading academic institutions and pharmaceutical companies will present data demonstrating the advantages of using the Guardant360® liquid biopsy test for clinical decision-making in advanced lung cancer at the IASLC 2021 World Conference on Lung Cancer hosted by the International Association for the ...
Guardant Health to Participate in the Morgan Stanley Global Healthcare...
Guardant Health to Participate in the Morgan Stanley Global Healthcare Conference REDWOOD CITY, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating virtually in the upcoming Morgan Stanley Global Healthcare Conference. Guardant Health’s management is scheduled to participate in a fireside chat on Thursday, September 9 at 1:15 p.m. Pacific Time / 4:15 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
SSYS STRATASYS LTD.
QADA QAD CLASS A
OCUL OCULAR THERAPEUTIX
NVTA INVITAE CORP
MPWR MONOLITHIC POWER SYSTEMS INC.
MGIC MAGIC SOFTWARE ENTERPRISES LTD.
LUNA LUNA INNOVATIONS
KFY KORN FERRY
ETSY ETSY INC.
DGII DIGI INTERNATIONAL INC.
BNFT BENEFITFOCUS INC.
BLFS BIOLIFE SOLUTIONS INC
CCRN CROSS COUNTRY HEALTHCARE INC.
IDT IDT CORP. CL B
NTLA INTELLIA THERAPEUTICS INC.
CRSP CRISPR THERAPEUTICS AG
FLGT FULGENT GENETICS
KALV KALVISTA PHARMACEUTICALS
ICHR ICHOR HOLDINGS LTD.
MED MEDIFAST INC.
MYOV MYOVANT SCIENCE
WNDW SOLARWINDOW TECHNOLOGIES INC
CELC CELCUITY
CELH CELSIUS HOLDINGS INC.
STRT STRATTEC SECURITY CORP.
SPRO SPERO THERAPEUTICS
RYTM RHYTHM PHARMACEUTICALS
SFIX STITCH FIX CLASS A
RUBY RUBIUS THERAPEUTICS
GH GUARDANT HEALTH
TBIO TRANSLATE BIO
NGM NGM BIOPHARMACEUTICALS
HOV HOVNANIAN ENTERPRISES INC. CLASS A
MRNA MODERNA INC.
CHWY CHEWY INC. CLASS A
FCEL FUELCELL ENERGY INC.
STOK STOKE THERAPEUTICS
NOVA SUNNOVA ENERGY INTERNATIONAL
NVAX NOVAVAX INC.
TXG 10X GENOMICS INC CLASS A
ARCT ARCTURUS THERAPEUTICS HOLDINGS INC
GRWG GROWGENERATION
NET CLOUDFLARE INC CLASS A
FREQ FREQUENCY THERAPEUTICS
TWST TWIST BIOSCIENCE
SDGR SCHRÖDINGER
LMND INC.
SPCE LEMONADE
CLPT INC.
ZNTL VIRGIN GALACTIC HOLDINGS (A)
BEAM CLEARPOINT NEURO INC
GBIO ZENTALIS PHARMACEUTICALS
FUBO BEAM THERAPEUTICS
ASPU GENERATION BIO
BEEM FUBOTV
HQI ASPEN GROUP
KLR BEAM GLOBAL
ONCS HIREQUEST INC.
PLRX KALEYRA
U ONCOSEC MEDICAL
PLIANT THERAPEUTICS
UNITY SOFTWARE
Guardant Health to Participate in Morgan Stanley 2020 Healthcare Confe...
Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. Guardant Health’s management is scheduled for a fireside chat on Tuesday, September 15 at 8:45 a.m. Pacific Time / 11:45 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: About Guardant HealthGuardant Health is ...
Guardant Health Receives FDA Emergency Use Authorization for its Guard...
Guardant Health Receives FDA Emergency Use Authorization for its Guardant-19 Next Generation Sequencing-Based COVID-19 Test COVID-19 diagnostic expands testing supply, protects the continuity of essential cancer work at Guardant Health, and helps with reopening at Delaware State University REDWOOD CITY, Calif., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) announces that the U.S. Food and Drug Administration (FDA) has granted the Guardant-19 test emergency use authorization (EUA) for use in the detection of the novel coronavirus, SARS-CoV-2. The test is being offe...
Guardant Health to Participate in Upcoming August Investor Conferences
Guardant Health to Participate in Upcoming August Investor Conferences REDWOOD CITY, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the following investor virtual conferences. UBS Genomics 2.0 and Medtech Innovations SummitFireside Chat on Tuesday, August 11th at 9 a.m. Pacific Time / 12 p.m. Eastern TimeCanaccord Virtual Growth ConferenceFireside Chat on Thursday, August 13th at 1 p.m. Pacific Time / 4 p.m. Eastern Time Interested parties may access a live and archived webcast of the presentation on the ...
Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for...
Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers Now FDA approved, the Guardant360 CDx delivers critical genomic information to oncologists from a simple blood draw REDWOOD CITY, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) announces that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx for tumor mutation profiling, also known as comprehensive genomic profiling (CGP), in patients with any solid malignant neoplasm (cancerous tumor). The Guardant360...
Guardant Health Reports Second Quarter 2020 Financial Results
Guardant Health Reports Second Quarter 2020 Financial Results Q2 2020 Revenue Increase of 23% Over Prior Year Period REDWOOD CITY, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended June 30, 2020. Recent Highlights Revenue of $66.3 million for the second quarter of 2020, an increase of 23% over the corresponding period of 2019 Precision oncolog...
Guardant Health Announces Collaboration with Radius Health to Develop ...
Guardant Health Announces Collaboration with Radius Health to Develop Liquid Biopsy Companion Diagnostic for Elacestrant Selective Estrogen Receptor Degrader in Phase III Trial For Use in Resistant ER-Positive Breast Cancer REDWOOD CITY, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced a strategic collaboration with Radius Health, Inc. (Radius, Nasdaq: RDUS) to pursue regulatory approval of the Guardant360® CDx as a companion diagnostic for elacestrant (RAD1901), an investigational selective estrogen receptor degrader (SERD) being studied in ...
Guardant Health Announces Webcast of Second Quarter Financial Results ...
Guardant Health Announces Webcast of Second Quarter Financial Results on August 6, 2020 REDWOOD CITY, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the second quarter 2020 after market close on Thursday, August 6, 2020. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the company website at: . The webcast will be archived and available for replay afte...
Guardant Health Announces Collaboration with Janssen to Develop Liquid...
Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic REDWOOD CITY, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced a strategic collaboration with Janssen Biotech, Inc. (Janssen) to pursue regulatory approval and commercialization of the Guardant360® CDx as a companion diagnostic for amivantamab, an investigational EGFR-MET bispecific antibody being studied in the treatment of non-small cell lung cancer (NSCLC). The agreement covers the United States, Canada, Japan, and Europe. “Studies continue to ...
Guardant Health Launches Real-World Clinical-Genomic Platform to Accel...
Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology Drug Development Represents a large-scale liquid biopsy dataset of advanced cancer patients REDWOOD CITY, Calif., June 23, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, addresses the challenges of developing new precision oncology medicines by unveiling the GuardantINFORM™ platform featuring an extensive clinical-genomic liquid biopsy dataset of advanced cancer patients. The GuardantINFORM platform is intended to help accelerate research...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.